New User Account Set Up

If you do not have an account with the Digest, please click on "Submit to the Digest." By logging in with your UCLA Login ID (formerly known as BOL Login), a new account will automatically be generated. If you experience any difficulties, please send an email to our help desk: drcsupport@mednet.ucla.edu.

Questions

If you have any questions or concerns, please email our help desk/support team: drcsupport@mednet.ucla.edu. We are more than happy to address any questions or concerns regarding the Weekly Message Digest system you may have.

How do I subscribe?

If you have a mednet email account (@mednet.ucla.edu), you should already be subscribed.

If you do not have a mednet email account or you are not receiving the Digest, please send an email to drcsupport@mednet.ucla.edu and we will add you to our list.

Overview of the UCLA Translational Oncology Research Laboratories

Title: “Overview of the UCLA Translational Oncology Research Laboratories”
Date & Time: Oct 18, 2012 12:00 PM - 1:00 PM
Location: 73-105 CHS


JCCC Research Seminar
12:00 – 1:00 PM
Room: 73-105 CHS
Richard Finn, M.D.
Associate Professor Department of Medicine, Division of Hematology/Oncology
Associate Director, JCCC Signal Transduction and Therapeutics Program Area
“Overview of the UCLA Translational Oncology Research Laboratories”
Sponsored by the Jonsson Comprehensive Cancer Center
Signal Transduction and Therapeutics Program Area
*Light Lunch Served

“Dr. Richard Finn is an Associate Professor of Medicine at the Geffen School of Medicine at UCLA in the Department of Medicine, Division of Hematology/ Oncology. He was an undergraduate at UCLA where he was involved with early laboratory studies investigating the HER2 oncogene and the development of monoclonal antibodies to this target in breast cancer with Dr. Dennis Slamon. He participated in the pre-clinical studies that defined the clinical candidate that eventually humanized and became the FDA approved agent trastuzumab (Herceptin). He went on to medical school at USC then returned to UCLA for his clinical training in Internal Medicine and then Hematology/ Oncology.

He currently splits his time between patient care and directing the Translational Research Laboratory in the Division of Hematology/ Oncology. His research interests are focused in the development of targeted therapeutics for solid tumors across histologies to support the larger efforts of the department. His personal interests lie in the development of these targeted agents in Hepato-biliary and breast cancers. He has two-half days dedicated to patient care, one of which is as a leader in the multi-disciplinary hepat-biliary cancer program at UCLA where he is involved with clinical studies aimed at bringing novel therapeutics into the treatment of patients with these malignancies.”

Posting Information
This posting expired on October 19, 2012.

Share this posting on social media!